1. Manufacturing Costs The cost of raw materials, production processes, and technology impacts the final price of aminophylline. As the pharmaceutical industry continues to innovate, these costs can fluctuate, leading to variations in drug pricing.
Once produced, APIs are typically combined with excipients to create a final pharmaceutical product. Excipients are inactive substances that serve as the vehicle for the API, aiding in drug formulation, stability, and delivery. The combination of API and excipients forms the final dosage form, such as tablets, capsules, or injectables.
Pentoxifylline, marketed as Trental 400 mg, remains a valuable option for managing disorders linked to poor peripheral circulation. Its ability to enhance blood flow and increase red blood cell flexibility positions it as a beneficial treatment for patients suffering from claudication and other related ailments. While it carries potential side effects and risks, the advantages often outweigh the drawbacks when used correctly under medical supervision. As research continues, pentoxifylline may find further applications in managing various health conditions, solidifying its place in modern therapeutics. Anyone prescribed this medication should engage in open dialogue with their healthcare provider to ensure optimal treatment outcomes.